fda compounding semaglutide news october 2025 A secret shopper study found that the majority of weight-loss clinics and medical spas in two states offered compounded tirzepatide and after shortages were resolved. Over half of the suppliers combined Beyond the Headlines: FDA Warning

doi: 10.3760/cma.j.issn.0366-6999.20113093 65 GullickNJAbozaidHSJayarajDMEvansHGScottDLChoyEHet al

The absence of negative data is not the same as confirmed safety, and your doctor can help you weigh the decision based on your individual situation

Medicare to start covering GLP-1 weight-loss therapies on July 1, 2026 May 2026 The Centers for Medicare & Medicaid Services (CMS) has launched the GLP-1 Bridge Program, a temporary initiative to provide coverage for effective weight-loss medications

It is technically a macronutrient rather than a supplement, but it is the single most impactful thing to prioritize on a GLP-1 medication